Navigation Links
Toxic waste sites cause healthy years of life lost
Date:5/3/2013

NEW YORK -- May 4, 2013 /Press Release/ Toxic waste sites with elevated levels of lead and chromium cause a high number of "healthy years of life lost" in individuals living near 373 sites located in India, Philippines and Indonesia, according to a study by a Mount Sinai researcher published online today in Environmental Health Perspectives.

The study leader, Kevin Chatham-Stephens, MD, Pediatric Environmental Health Fellow at the Icahn School of Medicine at Mount Sinai, presented the findings today at the Pediatric Academic Societies (PAS) annual meeting in Washington, DC. "Lead and hexavalent chromium proved to be the most toxic chemicals and caused the majority of disease, disability and mortality among the individuals living near the sites," said Dr. Chatham-Stephens, first author.

The study titled, "The Burden of Disease from Toxic Waste Sites in India, Indonesia, and the Philippines in 2010," was a joint research partnership between Mount Sinai and the Blacksmith Institute. Eight chemicals were sampled and collected at the toxic waste sites in 2010. The samples were then measured for pollutant levels in the soil and water and then compared with the 8,629,750 individuals who were at risk of exposure around these sites in order to calculate the loss of years of equivalent full health.

Researchers calculated healthy years of life lost due to ill-health, disability or early death, in disability-adjusted life years (DALY), a measure of overall disease burden used by the World Health Organization. One DALY represents the loss of one year of equivalent full health. In this study, the total number of lost years of full health or DALYs was 828,722. In comparison, malaria in the same countries caused 725,000 lost years of full health, and outdoor air pollution caused 1.4 million lost years of full health in 2008, according to Dr. Chatham-Stephens.

"The number of DALYs estimated in our study potentially places toxic
'/>"/>

Contact: Renatt Brodsky
Renatt.Brodsky@mountsinai.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Science surprise: Toxic protein made in unusual way may explain brain disorder
2. Joint air toxics research project among tribes, agencies recognized for partnership
3. When hungry, Gulf of Mexico algae go toxic
4. Home toxic home
5. How to thrive in battery acid and among toxic metals
6. Toxic oceans may have delayed spread of complex life
7. Is nanosilver toxic?
8. Nitrogen from pollution, natural sources causes growth of toxic algae, study finds
9. Scientists turn toxic by-product into biofuel booster
10. How our cells cope with toxic small molecules
11. Chemistry resolves toxic concerns about carbon nanotubes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2015)... and Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has announced the addition ... Report" report to their offering. This report analyzes ... by the following Segments: Face Biometrics, and Voice Biometrics. The report ... , Japan , Europe , ... & Africa , and Latin America ...
(Date:3/23/2015)... , March 23, 2015   HOYOS Labs , ... company, today announced that the Company will demonstrate multiple ... enterprise and consumers at Connect:ID on March 23 through ... HOYOS Labs will highlight the IEEE Biometric Open Protocol ... ; and enterprise access control system. BOPS was invented ...
(Date:3/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced ... Business Report" report to their offering. This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the ...
Breaking Biology News(10 mins):Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4
... Over the past decades, researchers seeking to understand molecular ... of DNA microarrays to interrogate tissues specimen of patients ... once. Jointly, such gene expression status of each ... their transcripts, constitutes the gene expression profile. Since each ...
... Researchers with the Faculty of Medicine & Dentistry at ... T-cells can kill neurons. This finding is significant because ... in the medical community as a potential treatment for ... and his post-doctoral fellow, Yohannes Haile, both from the ...
... but the DNA sequence of a small plant that ... information that could influence the development of candidate biofuel ... evolution. "When you burn coal, you,re burning ... Banks, who originally proposed that the U.S. Department of ...
Cached Biology News:Medusa-structure of gene regulatory network: Dominance of transcription factors in cancer subtypes 2Medusa-structure of gene regulatory network: Dominance of transcription factors in cancer subtypes 3Medusa-structure of gene regulatory network: Dominance of transcription factors in cancer subtypes 4Discovery demonstrates potential MS therapy could kill brain cells 2Spikemoss genome offers new paths for biofuels research -- bridges plant development gap 2Spikemoss genome offers new paths for biofuels research -- bridges plant development gap 3
(Date:4/20/2015)... 2015 Stent retriever thrombectomy, an endovascular ... the brain reduced disability after stroke, according to ... President of the Society of Vascular and Interventional ... giant step forward that will change the way ... said Jovin, who is associate professor of Neurology ...
(Date:4/20/2015)... Champaign, IL (PRWEB) April 20, 2015 ... establishment of its 12th clinical research site: PMG Research ... has assumed operation of the clinical research department at ... footprint outside the Southeast to a second region within ... 150 multi-specialty physician practice enhances PMG’s access to an ...
(Date:4/20/2015)... April 20, 2015  Ardelyx, Inc. (NASDAQ: ... cardio-renal, gastrointestinal and metabolic diseases, today announced that ... the Company,s Board of Directors. Dr. Jenkins brings ... experience, having built and led teams advancing programs ... and into healthcare systems globally. ...
(Date:4/20/2015)... Lilly and Company (NYSE: LLY ) will present ... Lilly,s diverse oncology pipeline, during the American Association for ... in Philadelphia , Pa.  ... of this year,s AACR meeting and one that is ... therapies that accelerate the pace and progress of cancer ...
Breaking Biology Technology:SVIN President Tudor Jovin, MD, Co-Leads Groundbreaking Stroke Study In The New England Journal Of Medicine 2SVIN President Tudor Jovin, MD, Co-Leads Groundbreaking Stroke Study In The New England Journal Of Medicine 3PMG Research Announces the Formation of its 12th Site in Champaign-Urbana, IL 2PMG Research Announces the Formation of its 12th Site in Champaign-Urbana, IL 3Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 2Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 3Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 4Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 2Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 3Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 4Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 5Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 6
... July 21 Innocoll Inc. today announced,that Anthony H. ... directors., Dr. Wild is a co-founder and General ... He is a member of the Boards,of Directors of ... the board of advisors of Ferrer,Freeman and Co., a ...
... diversity of research,approaches while also encouraging sharing of IP, technologies, partnerships ... ... reduced complexity, elimination of duplications and increased ... San Francisco,site to operate as an independent research and early development center ...
... The 2008 Kansas Day of,Innovation featuring the ... in Wichita, Kansas, Thursday, September 4th, 2008 at ... sponsors are focused,on providing early stage, high-growth companies ... early stage financing. "This has grown to,be a ...
Cached Biology Technology:Innocoll Appoints Anthony H. Wild Ph.D. to Its Board of Directors 2Innocoll Appoints Anthony H. Wild Ph.D. to Its Board of Directors 3Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 2Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 3Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 4Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 5Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 6Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 7Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 8Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 9Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 10Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 11Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 122008 Kansas Day of Innovation Featuring the Fifth Annual Great Plains Capital Conference Scheduled for September 2